Ozempic Weight loss pen

3 year ago

79 0

Shijiazhuang Asa Technology Co., Ltd.

 4 year year

Product details

Ozempic Semaglutide Injection (2mg/1.5mL) Lose Weight Removal Fat

Product Description

A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.

Based on the natural human GLP-1 molecule, the eighth (alanine → alpha-aminobutyric acid) and the 34th amino acid (lysine → arginine) were substituted, while lysine at the 26th was linked to the C18 adipose acid side chain by spacer group. After the modification of human GLP-1 molecule, Smeiglutide can resist the degradation of dipeptidyl peptidase 4 (DPP-4), bind closely to albumin, significantly prolong the half-life in vivo, achieve once a week administration, and retain up to 94% of GLP-1 amino acid sequence homology, with good safety.

In December 2017, the US Food and Drug Administration (FDA) approved Smegalutide injection for the control of blood sugar in adults with type 2 diabetes.

In January 2020, it was approved by the FDA to reduce the risk of major cardiovascular adverse events in adults with type 2 diabetes with cardiovascular disease.

On December 4, 2020, Novo Nordisk submitted to the FDA a marketing application for weight loss with Smeiglutide 2.4mg subcutaneously injected once a week.

In April 2021, it was approved by the State Food and Drug Administration (NMPA) for the treatment of adult type 2 diabetes mellitus and reducing the risk of cardiovascular adverse events in patients with T2DM combined with cardiovascular disease.

On December 3, 2021, it was included in the "National Basic Medical Insurance, industrial injury Insurance and maternity Insurance Drug Catalog (2021)".

character
This product is colorless or almost colorless clear isotonic liquid; pH=7.4.

Fold edit this paragraph for indications
This product is suitable for glycemic control in adults with type 2 diabetes: adults with type 2 diabetes who are treated with and/or sulfonylurea on the basis of diet control and exercise and still have poor glycemic control.

It is indicated to reduce the risk of major cardiovascular adverse events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes mellitus with cardiovascular disease.

Fold and edit this section specification
The specifications of this product are:

1.34mg/ml, 1.5ml (Pre-filled Injection pen)

1.34mg/ml, 3ml (Pre-filled Injection pen)

You May Also Like

Contact Now

If you are interested in the product, contact 2bvideo.com for more information for more information

To:: Shijiazhuang Asa Technology Co., Ltd.

Message:

Submit

Disclaimer：

The information of 2bvideo.com limited shown above is provided by the user or collected on the network. Video 2B does not guarantee the authenticity,accuracy and legitimacy of 2bvideo.com limited information. Video 2B does not involve legal relationships and disputes between users arising from transactions other than secured transactions on this website. Disputes shall be settled by you through negotiation. If you are the person in charge or relevant employee of this enterprise, if you find that the enterprise information is incorrect or want to manage thiscompany, please contact us jacklee1558@gmail.com, after you claim the enterprise, you can obtain management permission, publish supplyand demand information, bring consulting orders, and remove page advertisements.

Shijiazhuang Asa Technology Co., Ltd.

 Audited supplier

4 year

Address: Shijiazhuang, China

Main Product: PDO Thread, Dermal Filler , Micro Cannula, Hyaluronic Acid Injection, Mesotherapy Needle, Anti-wrinkle Products

 Contact now